What is an alternative funding program?
Alternative funding programs, or AFPs, are programs designed by companies and offered to employer-sponsored, self-funded health insurance plans to save the insurance company money.
AFPs only affect people with commercial, or private, health insurance.
How AFPs prevent access to medication.
AFPs could hurt patients' access to specialty medications and increase their out-of-pocket medication costs.
Specialty medications are expensive prescription drugs that treat rare, complex, and chronic health conditions. Even if a healthcare provider prescribes a specialty medication that is the best course of treatment for a person's condition, their health insurance plan may deny coverage and then require them to choose between enrolling in an alternative funding program or paying in full for the medication.
Ultimately, this delays or denies access to medications, and increases out-of-pocket costs for patients with rare and chronic health conditions.
How AFPs increase out-of-pocket expenses?
If the AFP is successful in receiving financial assistance from a patient assistance program, that patient will be able to use that support.
However, the plan will not count the value of this assistance towards a patients' annual out-of-pocket cost-sharing limit. This means that they could end up paying more out-of-pocket for the year.
Ways AFPs negatively impact patients.
Take action now! Email your Members of Congress and urge them to investigate and take action against AFPs.
Want to know if your health plan uses AFPs?
Visit PAN's Alternative Funding Education Hub to learn more about how AFPs prevent access to care and how to recognize them in your health plan.
Have you been affected by an AFP?
Share your story with the PAN Foundation. Your experience can help convey the negative impact AFPs can have on patients and their health and help lawmakers understand the negative impact AFPs can have on individuals with commercial insurance across the U.S.